Interview with Dr. Marco Tangelder: New Developments in the Clinical Development Landscape for Ophthalmology
November 13, 2018
Ophthalmology is a growing therapeutic area in clinical research with new and exciting developments occurring in the field, particularly in stem cell and gene cell therapies. Marco Tangelder, MD, Senior Medical Director, Medical department at Medpace highlights some of the advancements in Ophthalmology research and where the field is headed.
How Rare Diseases Are Showing the Way Toward Precision Medicine – Part 3
April 18, 2018
In our previous post, we discussed the approaches to help you identify, enroll and retain rare disease populations in clinical trials. Once the right patients have been enrolled in the trial, the challenge becomes measuring the efficacy of the experimental treatment and determining whether it’s producing the desired effect. However, invasive drug delivery methods, such as IV injection, can complicate this measurement and establishing whether the therapy actually reaches the target tissue can be difficult.
Important Cookie Information – This message will only appear once.